VIAF

Virtual International Authority File

Search

Leader     00000nz a2200037n 45 0
001     WKP|Q56855401  (VIAF cluster)  (Authority/Source Record)
003     WKP
005     20241221010844.0
008     241221nneanz||abbn n and d
035 ‎‡a  (WKP)Q56855401‏
024 ‎‡a  0000-0001-6276-4418‏ ‎‡2  orcid‏
035 ‎‡a  (OCoLC)Q56855401‏
100 0 ‎‡a  Allan Bastos Lima‏ ‎‡c  researcher‏ ‎‡9  en‏
375 ‎‡a  1‏ ‎‡2  iso5218‏
400 0 ‎‡a  Allan Bastos Lima‏ ‎‡c  wetenschapper‏ ‎‡9  nl‏
670 ‎‡a  Author's Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids‏
670 ‎‡a  wikidata authority control‏ ‎‡u  https://viaf.org/viaf/2150468315904172386‏
909 ‎‡a  (orcid) 0000000162764418‏ ‎‡9  1‏
919 ‎‡a  dualinhibitorsofthedengueandwestnilevirusns2bns3proteasessynthesisbiologicalevaluationanddockingstudiesofnovelpeptidehybrids‏ ‎‡A  Dual inhibitors of the dengue and West Nile virus NS2B-NS3 proteases: Synthesis, biological evaluation and docking studies of novel peptide-hybrids‏ ‎‡9  1‏
946 ‎‡a  b‏ ‎‡9  1‏
996 ‎‡2  DNB|1289641080
996 ‎‡2  SUDOC|182867870
996 ‎‡2  ISNI|0000000067796155
996 ‎‡2  PTBNP|36311
996 ‎‡2  LC|no2011055214
996 ‎‡2  ISNI|0000000069309912
996 ‎‡2  PTBNP|202128
996 ‎‡2  ISNI|0000000067968949
996 ‎‡2  LC|n 2024254245
996 ‎‡2  PTBNP|588935
996 ‎‡2  PTBNP|74159
996 ‎‡2  PTBNP|74098
996 ‎‡2  DNB|1288799810
996 ‎‡2  PTBNP|74136
996 ‎‡2  PTBNP|132234
996 ‎‡2  ISNI|0000000069822994
996 ‎‡2  ISNI|0000000497185928
996 ‎‡2  ISNI|0000000070130610
996 ‎‡2  PTBNP|74197
996 ‎‡2  BLBNB|001546190
996 ‎‡2  DNB|1188588818
996 ‎‡2  SUDOC|245240314
996 ‎‡2  PTBNP|101515
996 ‎‡2  ISNI|0000000117269215
996 ‎‡2  PTBNP|74106
996 ‎‡2  ISNI|0000000070433806
996 ‎‡2  NSK|000429086
996 ‎‡2  LC|no2013037586
997 ‎‡a  0 0 lived 0 0‏ ‎‡9  1‏
998 ‎‡a  Bastos Lima, Allan‏ ‎‡2  DNB|1139068962‏ ‎‡3  viafid‏ ‎‡3  title: (0.77, 'peptidehybridsasdualinhibitorsofthedengueandwestnilevirusproteases', 'dualinhibitorsofthedengueandwestnilevirusns2bns3proteasessynthesisbiologicalevaluationanddockingstudiesofnovelpeptidehybrids')‏